BL-B01D1 binds EGFR/HER3 on tumor cells, is internalized, and releases a topoisomerase I–inhibitor payload that causes DNA damage and apoptosis; killing is driven by EGFR/HER3 binding, not by DNA topoisomerase I expression itself.